Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram in severe asthma and MDD
NCT00621946Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Mar 2008
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) and severe asthma comparing Placebo with Escitalopram (2 arms). Primary endpoints: Hamilton Rating Scale for Depression at 12 weeks, Asthma Control Questionnaire at 12 weeks and 2 more. Started Mar 2008; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)severe asthma
Beyond the preview
Go deeper on NCT00621946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00621946.